WE'RE PARTNERING WITH PROVENTA INTERNATIONAL AT THE PHARMACOVIGILANCE STRATEGY MEETING IN BOSTON.
CLICK HERE TO USE YOUR VIP CODE FOR FREE REGISTRATION.
Ensuring drug safety from Clinical to Commercial
2
KEYNOTES
COLLEAGUES
100+
6
TOPIC AREAS
1
LOCATION
INTRODUCING
Real insights are shared in conversations, not lectures. That’s why our unique roundtable format guarantees real learning and ensures you only attend discussions that deliver value to you.
Facilitating all of the thought-provoking roundtables are our board of industry leaders and specialists in the field.
Take a look at some of the experts who will be speaking at our May and June Strategy Meetings.
DISCUSSIONS LEAD BY THE EXPERTS
Executive Director, PV Operations, Global Clinical Safety & Pharmacovigilance (GCSP)
CSL BEHRING
Richard Wolf
Vice President, Head of Drug Safety
KARUNA THERAPEUTICS
Edwin Raj
MODERNA THERAPEUTICS
Jane Caroll
Vice President, PV Operations
Executive Director, Head of Global Safety Science, DSPV
ULTRAGENYX
Barbara Morollo
PURDUE PHARMA L.P.
Sajjan Daniel
Vice President, Head of Drug Safety & Pharmacovigilance
DATAFOUNDRY.AI
Narasimha Kumar
Chief of Product Strategy and Commercialisation
DATAFOUNDRY.AI
Vivek Kalagara
Founder & CEO
Head of Safety &Pharmacovigilance
JOUNCE THERAPEUTICS
Jeff Roncal
This is certainly no typical conference format. Our unique events provide a modern way of networking and learning.
Intimate and interactive format where every voice is heard.
Stimulate your thinking and collaborate on fresh ideas
Debate Industry challenges through candid discussions
Join industry players from big pharma, biotech, research institutes and CROs...
Gain insights, stay competitive and benchmark against your peers
Signal Detection
Adverse Events/Case Processing
AI & Natural Language Processing
Patient Centricity & Real World Evidence
Risk Management
Evolving Pharmacovigilance
What you want to know. We speak to our wide network of senior decision-makers to ensure the most important topics are covered:
